Netskope Inc — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Netskope Inc filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $709.00M | Mar 31, 2026 |
| FY2026 | Jan 31, 2025 | $538.27M | Mar 31, 2026 |
| FY2026 | Jan 31, 2024 | $406.88M | Mar 31, 2026 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $709.00M | Mar 31, 2026 |
| FY2026 | Jan 31, 2025 | $538.27M | Mar 31, 2026 |
| FY2026 | Jan 31, 2024 | $406.88M | Mar 31, 2026 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $482.67M | Mar 31, 2026 |
| FY2026 | Jan 31, 2025 | $347.90M | Mar 31, 2026 |
| FY2026 | Jan 31, 2024 | $243.25M | Mar 31, 2026 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | ($679.39M) | Mar 31, 2026 |
| FY2026 | Jan 31, 2025 | ($354.51M) | Mar 31, 2026 |
| FY2026 | Jan 31, 2024 | ($344.85M) | Mar 31, 2026 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | ($652.58M) | Mar 31, 2026 |
| FY2026 | Jan 31, 2025 | ($255.74M) | Mar 31, 2026 |
| FY2026 | Jan 31, 2024 | ($312.80M) | Mar 31, 2026 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $509.03M | Mar 31, 2026 |
| FY2026 | Jan 31, 2025 | $254.19M | Mar 31, 2026 |
| FY2026 | Jan 31, 2024 | $224.50M | Mar 31, 2026 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $38.07M | Mar 31, 2026 |
| FY2026 | Jan 31, 2025 | ($110.68M) | Mar 31, 2026 |
| FY2026 | Jan 31, 2024 | ($167.17M) | Mar 31, 2026 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $22.92M | Mar 31, 2026 |
| FY2026 | Jan 31, 2025 | $33.70M | Mar 31, 2026 |
| FY2026 | Jan 31, 2024 | $30.61M | Mar 31, 2026 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $1.77B | Mar 31, 2026 |
| FY2026 | Jan 31, 2025 | $858.51M | Mar 31, 2026 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $1.58B | Mar 31, 2026 |
| FY2026 | Jan 31, 2025 | $1.34B | Mar 31, 2026 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $194.53M | Mar 31, 2026 |
| FY2026 | Jan 31, 2025 | ($485.59M) | Mar 31, 2026 |
| FY2026 | Jan 31, 2024 | ($256.82M) | Mar 31, 2026 |
| FY2026 | Jan 31, 2023 | $27.77M | Mar 31, 2026 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $61.08M | Mar 31, 2026 |
| FY2026 | Jan 31, 2025 | $61.08M | Mar 31, 2026 |
| FY2026 | Jan 31, 2024 | $57.18M | Mar 31, 2026 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | ($2.63B) | Mar 31, 2026 |
| FY2026 | Jan 31, 2025 | ($1.95B) | Mar 31, 2026 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $432.58M | Mar 31, 2026 |
| FY2026 | Jan 31, 2025 | $166.01M | Mar 31, 2026 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | (3) | Mar 31, 2026 |
| FY2026 | Jan 31, 2025 | (3) | Mar 31, 2026 |
| FY2026 | Jan 31, 2024 | (3) | Mar 31, 2026 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | (3) | Mar 31, 2026 |
| FY2026 | Jan 31, 2025 | (3) | Mar 31, 2026 |
| FY2026 | Jan 31, 2024 | (3) | Mar 31, 2026 |